Periodontal disease as a specific, albeit chronic, infection: Diagnosis and treatment

Clinical Microbiology Reviews

Volumn 14, Issue 4, 2001, Pages 727-752

  Loesche, W J ^a   Grossman, N S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIGEN; ANTIINFECTIVE AGENT; BACITRACIN; BUTYRIC ACID; C REACTIVE PROTEIN; CARBOXYLIC ACID; CEFALEXIN; CYTOKINE; DEFENSIN; ENZYME; ERYTHROMYCIN; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IODINE; LEUKOTOXIN; LIPOPOLYSACCHARIDE; METRONIDAZOLE; MINOCYCLINE; NEUTRALIZING ANTIBODY; PENICILLIN DERIVATIVE; PROPIONIC ACID; PROSTAGLANDIN; PROTEINASE; SHORT CHAIN FATTY ACID; TETRACYCLINE; UNINDEXED DRUG; VANCOMYCIN;

ANAEROBIC INFECTION; BACTERIUM CULTURE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DEBRIDEMENT; DEVICE; DNA PROBE; ENZYME ASSAY; GINGIVITIS; HEALTH CARE COST; HUMAN; HYGIENE; HYPOTHESIS; IMMUNE RESPONSE; INFECTION; NONHUMAN; PERIODONTAL DISEASE; POLYMERASE CHAIN REACTION; PORPHYROMONAS GINGIVALIS; PREVALENCE; REVIEW; RISK FACTOR; STROKE; TOOTH PLAQUE; TREPONEMA DENTICOLA;

ANAEROBIOSIS; CHRONIC DISEASE; DENTAL PLAQUE; GINGIVITIS; HUMANS; MODELS, BIOLOGICAL; MOUTH; PERIODONTAL DISEASES; TOOTH;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); BACTEROIDES; GOES; PORPHYROMONAS GINGIVALIS; TANNERELLA FORSYTHENSIS; TREPONEMA DENTICOLA; UNCULTURED ACTINOMYCETE;

EID: 0034767572     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.14.4.727-752.2001     Document Type: Review

References (346)

1. Microbiologic tests in epidemiologic studies: Are they reproducible?
2. Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans. A reservoir of periodontopathic bacteria
3. Ultrastructural observations on bacterial invasion in cementum and radicular dentin of periodontally diseased human teeth
4. Changes of periodontal status in patients with Down syndrome during a 7-year period
5. Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis
6. Intrafamilial transmission of Actinobacillus actinomycetemcomitans
7. Gingival state and dental calculus in early-onset periodontitis
8. Putative periodontal pathogens in subgingival plaque of young adults with and without early-onset periodontitis
9. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994
10. Gingival recession, gingival bleeding, and dental calculus in adults 30 years of age and older in the United States, 1988-1994
11. Crevicular fluid level of beta-glucuronidase in relation to clinical periodontal parameters and putative periodontal pathogens in early-onset periodontitis
12. Associations between six DNA probe-detected periodontal bacteria and alveolar bone loss and other clinical signs of periodontitis
13. Comparative detection frequency of 6 putative periodontal pathogens in Sudanese and Norwegian adult periodontitis patients
14. Comparison of the subgingival microbiota of periodontally healthy and diseased adults in northern Cameroon
15. Prevalence of 6 putative periodontal pathogens in subgingival plaque samples from Romanian adult periodontitis patients
16. Periodontopathic bacteria in children with Down syndrome
17. Development of a classification system for periodontal diseases and conditions
18. Relationship between the percentage of subgingival spirochetes and the severity of periodontal disease
19. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions
20. Occurrence of Actinobacillus actinomycetemcomitans and spirochetes in relation to age in localized juvenile periodontitis
21. Likelihood of transmitting Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in families with periodontitis
22. The immediate efficacy of adjunctive doxycycline in treatment of localized juvenile periodontitis
23. Clinical and laboratory characterization of early onset periodontitis
24. The roles of gingival epithelium and phagocytosing leukocytes in gingival defence
25. Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man
26. Dental infections and atherosclerosis
27. Periodontal treatment without maintenance. A retrospective study in 44 patients
28. Influence of cigarette smoking on vascular reaction during experimental gingivitis
29. The effect of a one-stage full-mouth disinfection on different intra-oral niches. Clinical and microbiological observations
30. Rapid identification of periodontal pathogens in subgingival plaque: Comparison of indirect immunofluorescence microscopy with bacterial culture for detection of Actinobacillus actinomycetemcomitans
31. Phenotypic assessment of early onset periodontitis in sibships
32. The capability of Actinobacillus actinomycetemcomitans. Bacteroides gingivalis, and Bacteroides intermedius to indicate progressive periodontitis: A retrospective study
33. The passage of tissue fluid into the clinically healthy gingival pocket
34. Early-onset periodontitis: Progression of attachment loss during 6 years
35. Prevalence, extent, severity and progression of periodontal disease
36. Periodontal status in the United States, 1988-91: Prevalence, extent and demographic variation
37. Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early-onset periodontitis patients
38. Early-onset periodontitis in Hispanic-American adolescents associated with A. actinomycetemcomitans
39. Diversity of cultivable and uncultivable oral spirochetes from a patient with severe destructive periodontitis
40. Phylogenetic analysis of pathogen-related oral spirochetes
41. Subgingival distribution of periodontal pathogenic microorganisms in adult periodontitis
42. Dental plaque and calculus: Risk indicators for their formation
43. Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. II. Correlation between immunofluorescence and culture techniques
44. Suppression of subgingival Actinobacillus actinomycetemcomitans in localized juvenile periodontitis by systemic tetracycline
45. Early-onset periodontitis associated with Down's syndrome - Clinical interventional study
46. Crevicular fluid update
47. Body geometry of patients who had recurrent attacks of acute necrotizing ulcerative gingivitis
48. Clinical and microbiological features of refractory periodontitis subjects
49. Comparison of periodontal disease in HIV seropositive subjects and controls. II. Microbiology, immunology and predictors of disease progression
50. The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases: 12-month results
51. Occurrence of enteric rods, staphylococci and Candida in subgingival samples
52. Chronic infections and coronary heart disease: Is there a link?
53. Dental disease and risk of coronary heart disease and mortality
54. Acute ulcerative gingivitis. A double blind controlled clinical trial of metronidazole
55. The predominant cultivable microbiota of active and inactive lesions of destructive periodontal diseases
56. Longitudinal dynamics of infection and serum antibody in A. actinomycetemcomitans periodontitis
57. The relationship of antibody response categories to clinical parameters of periodontal disease
58. Human immune responses to oral micro-organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to Actinobacillus actinomycetemcomitans
59. Human immune responses to oral microorganisms. II. Serum antibody responses to antigens from Actinobacillus actinomycetemcomitans and the correlation with localized juvenile periodontitis
60. Humoral immune responses and diagnosis of human periodontal disease
61. The microbiota of periodontal pockets with different depths in therapy-resistant periodontitis
62. Microbiological study of localized juvenile periodontitis in Panama
63. Epidemiological and biochemical studies of necrotizing ulcerative gingivitis and noma (cancrum oris) in Nigerian children
64. Microbiological understandings and mysteries of noma (cancrum oris)
65. The relationship between plaque BANA reactivity and clinical parameters in subjects with mental disabilities
66. Treatment of anaerobic infections: An overview
67. Plaque microbiology and caries
68. Neutrophil dysfunctions, IL-8, and soluble L-selectin plasma levels in rapidly progressive versus adult and localized juvenile periodontitis: Variations according to disease severity and microbial flora
69. Relationship of stress, distress and inadequate coping behaviors to periodontal disease
70. 1985 Kreshover lecture. Molecular factors influencing neutrophil defects in periodontal disease
71. Serum and gingival fluid antibodies as adjuncts in the diagnosis of Actinobacillus actinomycetemcomitans-associated periodontal disease
72. Present concepts concerning the etiology and treatment of acute necrotizing ulcerative gingivitis
73. Antimicrobial strategies for treatment of periodontal disease
74. Multicenter evaluation of tetracycline fiber therapy. II. Clinical response
75. Antibiotics and control of plaque-related diseases
76. Patterns of progression and regression of advanced destructive periodontal disease
77. Efficacy of clindamycin hydrochloride in refractory periodontitis: 24-Month results
78. Clinical documentation and occurrence of putative periodontopathic bacteria in human immunodeficiency virus-associated periodontal disease
79. A randomized controlled trial of a 2% minocycline gel as an adjunct to non-surgical periodontal treatment, using a design with multiple matching criteria
80. Degradation of host protease inhibitors and activation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola
81. Nutritional interactions between two suspected periodontopathogens, Treponema denticola and Porphyromonas gingivalis
82. Prevalence of Porphyromonas gingivalis and periodontal health status
83. Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss
84. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss
85. A PCR-DNA probe assay specific for Bacteroides forsythus
86. Enumeration of subgingival species on primary isolation plates using colony lifts
87. Actinobacillus actinomycetemcomitans in families afflicted with periodontitis
88. Serum antibodies to periodontal bacteria
89. Periodontal therapy in young adults with severe generalized periodontitis
90. Combined antibiotic (metronidazole) and mechanical treatment effects on the subgingival bacterial flora of sites with recurrent periodontal disease
91. A panel of probes detects DNA polymorphisms in human and non-human primate isolates of a periodontal pathogen. Actinobacillus actinomycetemcomitans
92. The effect of SRP on the clinical and microbiological parameters of periodontal diseases
93. Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects
94. Frequency distributions of periodontal attachment loss. Clinical and microbiological features
95. Microbial etiological agents of destructive periodontal diseases
96. Clinical, microbiological and immunological features of subjects with destructive periodontal diseases
97. Microbial risk indicators for periodontal attachment loss
98. The use of DNA probes to examine the distribution of subgingival species in subjects with different levels of periodontal destruction
99. Plaque microbiology in health and disease
100. Bacteriological study of juvenile periodontitis in China
101. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis
102. Identification of pathogens in atheromatous plaques
103. Relationship of subgingival plaque flora to lysosomal and cytoplasmic enzyme activity in gingival crevicular fluid
104. Genetic considerations of risk in human periodontal disease
105. Genetic studies of syndromes with severe periodontitis and palmoplantar hyperkeratosis
106. Quality assessment and meta-analysis of systemic tetracycline use in chronic adult periodontitis
107. A long-term survey of tooth loss in 600 treated periodontal patients
108. A sensitive enzymatic method (SK-013) for detection and quantification of specific periodontopathogens
109. Progression of probing attachment loss in adult periodontitis
110. Effects of butyrate and propionate on the adhesion, growth, cell cycle kinetics, and protein synthesis of cultured human gingival fibroblasts
111. Clinical and microbiological effects of controlled-release locally delivered minocycline in periodontitis
112. Microbiota of rapidly progressive periodontitis lesions in association with clinical parameters
113. Predominant microflora of severe, moderate and minimal periodontal lesions in young adults with rapidly progressive periodontitis
114. Research in dental caries
115. A rationale for management of periodontal diseases: Rapid identification of microbial 'therapeutic targets' with phase-contrast microscopy
116. Relationship between serum antibody levels and subgingival colonization of Porphyromonas gingivalis in patients with various types of periodontitis
117. The influence of supragingival plaque control on clinical and microbial outcomes following the use of antibiotics for the treatment of periodontitis
118. Proteases of Porphyromonas gingivalis: What don't they do?
119. Volatile fatty acid, metabolic by-product of periodontopathic bacteria, induces apoptosis in WEHI 231 and RAJI B lymphoma cells and splenic B cells
120. Microbiological features and crevicular fluid aspartate aminotransferase enzyme activity in early onset periodontitis patients
121. Clinical and microbiological effects of subgingival restorations with overhanging or clinically perfect margins
122. Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: Role of active enzyme in human periodontitis
123. Impact of microbiological consultation on clinical decision making: A case-control study of clinical management of recurrent periodontitis
124. The short-term effect of apically repositioned flap surgery on the composition of the subgingival microbiota
125. Some microbiological, histopathological and immunohistochemical characteristics of progressive periodontal disease
126. Effect of ligature placement and dental plaque on periodontal tissue breakdown in the dog
127. Treatment of localized juvenile periodontitis. Results after 5 years
128. Effect of long-term tetracycline therapy on human periodontal disease
129. Some microbiological and histopathological features of periodontal disease in man
130. Long-term maintenance of patients treated for advanced periodontal disease
131. DNA probe detection of Eikenella corrodens, Wolinella recta and Fusobacterium nucleatum in subgingival plaque
132. Electron microscopic observations on the bacterial flora of acute necrotizing ulcerative gingivitis
133. Monitoring the periodontal microbiota as an adjunct to periodontal therapy: Rationale, interpretation of test results and application to patient management
134. Structure of the microbial flora associated with periodontal health and disease in man. A light and electron microscopic study
135. Relative distribution of bacteria at clinically healthy and periodontally diseased sites in humans
136. Microbial composition and pattern of antibiotic resistance in subgingival microbial samples from patients with refractory periodontitis
137. Incidence of periodontitis recurrence in treated patients with and without cultivable Actinobacillus actinomycetemcomitans, Prevotella intermedia, and Porphyromonas gingivalis: A prospective study
138. Detection of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Bacteroides forsythus in an A. actinomycetemcomitans-positive patient population
139. Oral microflora as a cause of endocarditis and other distant site infections Infect
140. Plaque control in periodontal disease
141. Early onset periodontitis in the United States of America
142. Experimental gingivitis in man
143. The antimicrobial treatment of periodontal disease: Changing the treatment paradigm
144. Association of the oral flora with important medical diseases
145. Role of Streptococcus mutans in human dental decay
146. Development of a diagnostic test for anaerobic periodontal infections based on plaque hydrolysis of benzoyl-DL-arginine-naphthylamide
147. The utility of the BANA test for monitoring anaerobic infections due to spirochetes (Treponema denticola) in periodontal disease
148. Metronidazole in periodontitis: Reduced need for surgery
149. Nonsurgical treatment of patients with periodontal disease
150. Metronidazole in periodontitis. IV. The effect of patient compliance on treatment parameters
151. Relationship between oxygen tension and subgingival bacterial flora in untreated human periodontal pockets
152. The optimization of the BANA test as a screening instrument for gingivitis among subjects seeking dental treatment
153. Comparison of the benzoyl-DL-arginine-naphthylamide (BANA) test, DNA probes, and immunological reagents for ability to detect anaerobic periodontal infections due to Porphyromonas gingivalis, Treponema denticola, and Bacteroides forsythus
154. Comparison of various detection methods for periodontopathic bacteria: Can culture be considered the primary reference standard?
155. Effects of metronidazole on periodontal treatment needs
156. Assessing the relationship between dental disease and coronary heart disease in elderly U.S. veterans
157. Bacteriology of human experimental gingivitis: Effect of plaque and gingivitis score
158. The bacteriology of acute necrotizing ulcerative gingivitis
159. Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks
160. Bacterial profiles of subgingival plaques in periodontitis
161. A logistic regression model for the decision to perform access surgery
162. Role of spirochetes in periodontal disease
163. Early onset periodontitis: A tale of two infection
164. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis
165. Effects of metronidazole plus amoxicillin in progressive untreated adult periodontitis: Results of a single 1-week course after 2 and 4 months
166. Occurrence of certain bacterial species and morphotypes in juvenile periodontitis in Chile
167. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia in juvenile periodontitis J
168. Molecular detection of Bacteroides forsythus in human periodontitis
169. Evaluation of periodontal treatments using controlled-release tetracycline fibers: Microbiological response
170. Subgingival microbial profile of Papillon-Lefevre patients assessed by DNA-probes
171. Bacterial mechanisms in periodontal disease
172. Multiparameter flow cytometric analysis of polymorphonuclear leucocytes in whole blood from patients with adult rapidly progressive periodontitis reveals low expression of the adhesion molecule L-selectin (Cd62L)
173. Longitudinal study of predictive factors for periodontal disease and tooth loss
174. Dark ground microscopy in relation to 3 clinical parameters of chronic inflammatory periodontal disease
175. "Checkerboard" DNA-probe analysis and anaerobic culture of initial periodontal lesions
176. Subgingival temperature and microbiota in initial periodontitis
177. The peptidolytic capacity of the spirochete system
178. Calculus update: Prevalence, pathogenicity and prevention
179. Clinical immunologic and microbiologic features of active disease sites in juvenile periodontitis
180. Microbiological and clinical effects of surgery plus doxycycline on juvenile periodontitis
181. A selective medium for Actinobacillus actinomycetemcomitans and the incidence of the organism in juvenile periodontitis
182. The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis
183. Evaluating patient perceptions as short-term outcomes of periodontal treatment: A comparison of surgical and non-surgical therapy
184. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke
185. Tooth loss in 100 treated patients with periodontal disease. A long-term study
186. The long-term effectiveness of periodontal therapy in a clinical practice
187. Comparison of DNA probe and ELISA microbial analysis methods and their association with adult periodontitis
188. Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigrescens, and Actinobacillus actinomyetemcomitans after mechanical therapy of periodontal disease
189. Topographic distribution of black-pigmenting anaerobes before and after periodontal treatment by local delivery of tetracycline
190. Use of synthetic oligonucleotide DNA probes for the identification of Bacteroides gingivalis
191. Use of synthetic oligonucleotide DNA probes for identification and direct detection of Bacteroides forsythus in plaque samples
192. Bacteriology of experimental gingivitis in children
193. Bacteriology of experimental gingivitis in young adult humans
194. The microflora of periodontal sites showing active destructive progression
195. The bacteria of periodontal diseases
196. Molecular epidemiology of oral treponemes associated with periodontal disease
197. Effect of sampling on the composition of the human subgingival microbial flora
198. Morphological compositions of subgingival microbiota in Actinobacillus actinomycetemcomitans-associated periodontitis
199. DNA probe detection of periodontal pathogens in HIV-associated periodontal lesions
200. Immunological, genetic, and microbiological study of family members manifesting early-onset periodontitis
201. Periodontal disease and NIDDM in Pima Indians
202. Predominant cultivable microbiota in periodontosis
203. The relationship of gingival crevicular fluid short chain carboxylic acid concentration to gingival inflammation
204. Short-chain carboxylic acid concentration in human gingival crevicular fluid
205. Short-chain carboxylic-acid-stimulated, PMN-mediated gingival inflammation
206. Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis
207. Compliance with supportive periodontal therapy and its relation to the bleeding index
208. Early-onset periodontitis
209. Modulation of host PGE2 secretion as a determinant of periodontal disease expression
210. The microbial morphotypes associated with periodontal health and adult periodontitis: Composition and distribution
211. Induction of prostaglandin release from macrophages by bacterial endotoxin
212. Periodontal diseases in the United States population
213. Defective neutrophil and monocyte motility in patients with early-onset periodontitis
214. Periodontal diseases: Epidemiology
215. Subgingival microbiota in adult Chinese: Prevalence and relation to periodontal disease progression
216. "Checkerboard" versus culture: A comparison between two methods for identification of subgingival microbiota
217. An analysis of the subgingival microflora in randomly selected subjects
218. Trypsin-like activity levels of Treponema denticola and Porphyromonas gingivalis in adults with periodontitis
219. Comparative clinical and microbiological effects of topical subgingival application of metronidazole 25% dental gel and scaling in the treatment of adult periodontitis
220. Relationship between levels of aspartate aminotransferase in gingival crevicular fluid and gingival inflammation
221. The capacity of subgingival microbiotas to produce volatile sulfur compounds in human serum
222. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria
223. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results
224. Treatment of rapidly destructive periodontitis in Papil-Ion-Lefevre syndrome. Laboratory and clinical observations
225. One stage full-versus partial-mouth disinfection in the treatment of chronic adult or generalized early-onset periodontitis. II. Long-term impact on microbial load
226. Microbiological study of HIV-related periodontitis
227. Utility of 5 major putative periodontal pathogens and selected clinical parameters to predict periodontal breakdown in patients on maintenance care
228. The relationship between oral malodor, gingivitis, and periodontitis. A review
229. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
230. Comparison of polymerase chain reaction and culture methods for detection of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in subgingival plaque samples
231. Association of oral spirochetes from periodontally healthy sites with development of gingivitis
232. Association of oral spirochetes from sites of periodontal health with development of periodontitis
233. Relative proportions of pathogen-related oral spirochetes (PROS) and Treponema denticola in supragingival and subgingival plaque from patients with periodontitis
234. Subgingival distribution of Treponema denticola, Treponema socranskii, and pathogen-related oral spirochetes: Prevalence and relationship to periodontal status of sampled sites
235. Periodontal status and detection frequency of bacteria at sites of periodontal health and gingivitis
236. Detection of pathogen-related oral spirochetes, Treponema denticola, and Treponema socranskii in dental plaque from dogs
237. Identification of spirochetes related to Treponema pallidum in necrotizing ulcerative gingivitis and chronic periodontitis
238. Pathogen-related spirochetes identified within gingival tissue from patients with acute necrotizing ulcerative gingivitis
239. The possible role of hydrogen sulfide in human periodontal disease. I. Hydrogen sulfide production in periodontal pockets
240. Dental bacteremia in children Pediatr
241. Occurrence of Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in severe periodontitis in relation to age and treatment history
242. A bacteriological survey of gingival scrapings from periodontal infections by direct examination, guinea pig inoculation, and anaerobic cultivation
243. Prevalence of periodontal disease in young diabetics
244. Scanning electron microscope and intragingival microorganisms in periodontal diseases
245. PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression
246. Site selection criteria for microbiological testing of periodontal microorganisms
247. Distribution of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis by subject age
248. DNA probes in the diagnosis of periodontal microorganisms
249. Distribution of certain subgingival microbial species in selected periodontal conditions
250. Comparison of cultural methods and DNA probe analyses for the detection of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis, and Bacteroides intermedius in subgingival plaque samples
251. Metronidazole in the treatment of localized juvenile periodontitis
252. Non-human primates used in studies of periodontal disease pathogenesis: A review of the literature
253. The gingival tissues: The architecture of periodontal protection
254. Azithromycin in the treatment of periodontal disease. Effect on microbial flora
255. Subacute bacterial endocarditis due to Actinobacillus actinomycetemcomitans
256. The biochemical milieu of the host in the selection of anaerobic species in the oral cavity
257. Sequential manifestation of different forms of early-onset periodontitis. A case report
258. Vincent's disease and its treatment
259. Type 2 diabetes mellitus and periodontal disease
260. Bacterial synergy of Treponema denticola and Porphyromonas gingivalis in a multinational population
261. Treponema denticola and Porphyromonas gingivalis as prognostic markers following periodontal treatment
262. Acute-phase inflammatory response to periodontal disease in the US population
263. The predominant cultivable organisms in juvenile periodontitis
264. Selective medium for isolation of Actinobacillus actinomycetemcomitans
265. Subgingival microflora and periodontal disease
266. Relationship between some subgingival bacteria and periodontal pocket depth and gain or loss of periodontal attachment after treatment of adult periodontitis
267. Actinobacillus actinomycetemcomitans and Bacteroides intermedius in human periodontitis: Age relationship and mutual association
268. Yeasts, enteric rods and pseudomonads in the subgingival flora of severe adult periodontitis
269. Actinobacillus actinomycetemcomitans in human periodontal disease: A cross-sectional microbiological investigation
270. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline
271. Actinobacillus actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and treatment
272. Analytical performance of an immunologic-based periodontal bacterial test for simultaneous detection and differentiation of Actinobacillus actinomycetemcomitans. Porphyromonas gingivalis, and Prevotella intermedia
273. Effect of therapy on periodontal infections
274. Microbial complexes in subgingival plaque
275. Relationship of subgingival microbial complexes to clinical features at the sampled sites
276. Relation of counts of microbial species to clinical status at the sampled site
277. "Checkerboard" DNA-DNA hybridization
278. An approach to the definition of periodontal disease syndromes by cluster analysis
279. Longitudinal effect of nonsurgical treatment and systemic metronidazole for 1 week in smokers and non-smokers with refractory periodontitis: A 5-year study
280. DNA probe detection of periodontopathogens in advanced periodontitis
281. Spirochaetes and granulocytes at sites involved in periodontal disease
282. Genetic approaches in the study of periodontal disease
283. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases
284. Sustained local delivery of chlorhexidine in the treatment of periodontitis: A multi-center study
285. Bacteriology of human experimental gingivitis: Effect of plaque age
286. Elevated humoral immune response to heat shock protein 60 (hsp60) family in periodontitis patients
287. Effect of initial periodontal therapy on the frequency of detecting Bacteroides forsythus, Porphyromonas gingivalis, and Actinobacillus actinomycetemcomitans
288. Antimicrobial activity of metronidazole in anaerobic bacteria
289. Microbiota of health, gingivitis, and initial periodontitis
290. A study of the bacteria associated with advancing periodontitis in man
291. Rapid chair-side DNA probe assay of Bacteroides forsythus and Porphyromonas gingivalis
292. Evaluation of a nonradioactive DNA probe for detecting Porphyromonas gingivalis in subgingival specimens
293. Relationship between gingival crevicular fluid and serum antibody titers in young adults with generalized and localized periodontitis
294. Serum antibodies in young adult humans reactive with periodontitis associated treponemes
295. Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation
296. Evaluation of the long-term efficacy and safety of locally-applied minocycline in adult periodontitis patients
297. Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis
298. The collagenolytic activity of Treponema denticola
299. Cytopathic effects of Treponema denticola chymotrypsin-like proteinase on migrating and stratified epithelial cells
300. Collagenolytic enzymes in periodontal diseases
301. Extraction of collagenase from human gingiva
302. Microbial flora in the acute phase of periodontitis and the effect of local administration of minocycline
303. Selling biotechnology in the dental medicine marketplace: The OmniGene Diagnostics DNA probe tests for periodontal pathogens
304. The use of tetracycline-containing controlled-release fibers in the treatment of refractory periodontitis
305. Prevalence of periodontal breakdown in adolescents and presence of Actinobacillus actinomycetemcomitans in subjects with attachment loss
306. Clinical, microbiological and immunological studies of a family with a high prevalence of early-onset periodontitis
307. Neutrophil function and oral disease
308. Neutrophil chemotaxis in families with localized juvenile periodontitis
309. Neutrophil surface protein markers as indicators of defective chemotaxis in LJP
310. Discrepancy between culture and DNA probe analysis for the detection of periodontal bacteria
311. Metronidazole plus amoxicillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis
312. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis
313. Healing of the dento-epithelial junction following subgingival plaque control. II. As observed on extracted teeth
314. Epithelial antimicrobial peptides: Review and significance for oral applications
315. Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius: Predictors of attachment loss?
316. The effect of supragingival plaque control on the progression of advanced periodontal disease
317. Autoimmunity and atherosclerosis
318. Assessment of serum antibody patterns and analysis of subgingival microflora of members of a family with a high prevalence of early-onset periodontitis
319. Periodontal disease
320. How patient compliance to suggested oral hygiene and maintenance affect periodontal therapy
321. Clinical and microbiological effects of initial periodontal therapy in conjunction with amoxicillin and clavulanic acid in patients with adult periodontitis. A randomised double-blind, placebo-controlled study
322. Effects of metronidazole in patients with "refractory" periodontitis associated with Bacteroides forsythus
323. Periodontal disease associated with HIV infection
324. Coronal and root caries in the dentition of adults in the United States, 1988-1991
325. Bacteria as risk markers for periodontitis
326. Natural distribution of 5 bacteria associated with periodontal disease
327. Microbial interpretation of plaque relative to the diagnosis and treatment of periodontal disease
328. Distinct categories of microbial forms associated with periodontal disease J
329. Microbiological response of localized sites with recurrent periodontitis in maintenance patients treated with tetracycline fibers
330. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: Clinical significance determined in a follow-up study
331. Relationship between peptidase activity from Treponema denticola, Porphyromonas gingivalis, and Bacteroides forsythus and attachment loss
332. Familial transmission of periodontal pathogens as a risk factor for periodontal disease progression
333. Principles of evaluation of the diagnostic value of subgingival bacteria
334. Rapid diagnosis of periodontal infections: Findings in AIDS patients
335. Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families
336. Cigarette smoking increases the risk for subgingival infection with periodontal pathogens
337. Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease
338. Molecular genetic analysis of Actinobacillus actinomycetemcomitans epidemiology
339. Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease
340. Comparison of serological and DNA probe analyses for detection of suspected periodontal pathogens in subgingival plaque samples